La insulina subcutánea continua es una inyección continua de insulina subcutánea.

Same author

Integrated assessment of the effects of PFOA exposure on hepatic transcriptome and lipid profiles in mice expressing human PPARα.

Toxicology and applied pharmacology·2025

Same author

Perfluorooctanoic acid increases serum cholesterol in a PPARα-dependent manner in female mice.

Archives of toxicology·2025

Same author

Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Toxicology and applied pharmacology·2020

Same author

Contingent negative variation: a biomarker of abnormal attention in functional movement disorders.

European journal of neurology·2020

Same author

Physical treatment of functional neurologic disorders.

Handbook of clinical neurology·2016

Same author

Randomised feasibility study of physiotherapy for patients with functional motor symptoms.

Journal of neurology, neurosurgery, and psychiatry·2016

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

La insulina subcutánea continua es una inyección continua de insulina subcutánea.

Videos de Conceptos Relacionados

Integrated assessment of the effects of PFOA exposure on hepatic transcriptome and lipid profiles in mice expressing human PPARα.

Perfluorooctanoic acid increases serum cholesterol in a PPARα-dependent manner in female mice.

Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Contingent negative variation: a biomarker of abnormal attention in functional movement disorders.

Physical treatment of functional neurologic disorders.

Randomised feasibility study of physiotherapy for patients with functional motor symptoms.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

La insulina subcutánea continua es una inyección continua de insulina subcutánea.

Videos de Conceptos Relacionados

Artículos Relacionados

Integrated assessment of the effects of PFOA exposure on hepatic transcriptome and lipid profiles in mice expressing human PPARα.

Perfluorooctanoic acid increases serum cholesterol in a PPARα-dependent manner in female mice.

Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Contingent negative variation: a biomarker of abnormal attention in functional movement disorders.

Physical treatment of functional neurologic disorders.

Randomised feasibility study of physiotherapy for patients with functional motor symptoms.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.